spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  age-related disease 

 HSMN NewsFeed - 19 Nov 2021
Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 7 Sep 2020
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Mar 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2020
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jul 2018
Ascentage Pharma Raises $150 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jun 2018
AbbVie and Calico Announce Extension of Groundbreaking Collaboration
Biopharmaceuticals Neurology Oncology
 HSMN NewsFeed - 19 Mar 2018
UNITY Biotechnology, Inc. Completes $55 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Aug 2017
Alkahest Appoints Helen Jenkins as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Jan 2017
Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2016
4Tech Elects Ex-Medtronic CEO William (“Bill”) A. Hawkins as its Chairman
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 7 Sep 2010
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2008
Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2007
Elixir Pharmaceuticals Names Gregory D. Perry as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2007
Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 18 Dec 2006
Advaxis Names Thomas A. Moore to Serve as CEO and Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2006
Hercules Provides $15 Million of Financing to Elixir Pharmaceuticals, Inc., a Leading Biopharmaceutical Company
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Elixir Pharmaceuticals Raises $46 Million
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
age-related disease
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.